Neuroimaging in Parkinson's Disease and Related Disorders discusses the advances of molecular, structural and functional neuroimaging techniques associated with the etiology, pathophysiology, effects and complications of novel therapies in Parkinson's and related disorders. With new neuroimaging methodologies emerging over the past five years, this book provides a comprehensive overview of new technologies and research. Sections discuss the biomarker value of neuroimaging of the brain to understand disease progression in vivo in actual patients with Parkinson's disease and related disorders. Readers will be updated on in vivo pathology and pathophysiology in Parkinson's disease and in a number of related disorders.
Also discussed is the association between clinical symptoms, clinical progression, and molecular, structural, and functional changes in the brain of patients with Parkinson's disease and related disorders.
- Comprehensive overview of biomarker value of neuroimaging of the brain to understand disease progression in vivo in actual patients with Parkinson's disease and related disorders
- Helps readers understand the in vivo pathology and pathophysiology in Parkinson's disease and in a number of related disorders
- Discusses the association between clinical symptoms, clinical progression, and molecular, structural, and functional changes in the brain of patients with Parkinson's and related disorders
Sprache
Verlagsort
Verlagsgruppe
Elsevier Science & Techn.
Dateigröße
ISBN-13
978-0-12-821652-1 (9780128216521)
Schweitzer Klassifikation
Section I. Introduction1. Parkinson's disease and related disorders: The pursuit for reliable readouts and the role of neuroimaging2. Advances in magnetic resonance imaging3. Advances in molecular neuromaging methodology
Section II. Clinical Applications in Parkinson's Disease4. Dopaminergic molecular imaging in familial and idiopathic Parkinson's disease5. Serotonergic molecular imaging in familial and idiopathic PD6. Molecular imaging beyond dopamine and serotonin in familial and idiopathic Parkinson's disease7. Structural MRI in familial and idiopathic PD8. Functional MRI in familial and idiopathic PD9. Molecular imaging in prodromal Parkinson's disease
Section III. Clinical Applications in Lewy Body Dementias10. Molecular imaging evidence in favor or against PDD and DLB overlap11. Magnetic resonance imaging in Parkinson's disease with mild cognitive impairment, Parkinson's disease dementia, and dementia with Lewy bodies
Section IV. Clinical Applications in Atypical Parkinsonian Disorders12. Neuroimaging in multiple system atrophy13. Neuroimaging in progressive supranuclear palsy14. Neuroimaging in corticobasal syndrome
Section V. Clinical Applications in Other Movement Disorders15. Molecular imaging in Huntington's disease16. Magnetic resonance imaging in Huntington's disease17. Neuroimaging in essential tremor 18. Neuroimaging in restless legs syndrome 19. Neuroimaging in dystonia20. Demyelinating syndromes and movement disorders
